Gilde Healthcare Private Equity IV (GHPE IV) has closed at €517m for investments in proifitable healthcare companies in the lower mid-market in North-west Europe.
The new oversubscribed fund will focus its investements on firms with an active buy-and-build strategy and is designed to invest in all sub-segments of the healthcare sector. These include companies in healthcare provision, service providers to the healthcare sector and medical industry, manufacturers of medical supplies and pharmaceutical companies. According to the Utrecht-headquartered equity firm, institutional investors came from the Netherlands, Germany, United Kingdom, France, Italy, and Scandinavia.
